300522SZSE

Independent Director's Work Report for 2025 of Suzhou Shiming Technology Co., Ltd. (Sun Hongxing)

✨ AI Summary

This report outlines the performance of independent director Sun Hongxing for the year 2025, emphasizing adherence to legal regulations and company policies. Key activities included attending all board and shareholder meetings, chairing the audit committee, and ensuring compliance in financial reporting. The report confirms no conflicts of interest and highlights the protection of minority shareholders' rights.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Independent Director's Work Report for 2025

Sun Hongxing

Dear shareholders and representatives:

As an independent director of Suzhou Shiming Technology Co., Ltd. (hereinafter referred to as "the Company"), I strictly adhere to the "Company Law of the People's Republic of China," "Measures for the Administration of Independent Directors of Listed Companies," "Shenzhen Stock Exchange GEM Listing Rules," and other relevant laws and regulations, as well as the "Articles of Association" and "Independent Director Work System" of the Company. In my work for the year 2025, I continuously focused on the Company's operational status and faithfully fulfilled my responsibilities as an independent director, fully leveraging my role in decision-making, supervision, and professional consultation to protect the legitimate rights and interests of the Company and all shareholders, especially minority investors. In accordance with regulatory requirements and the actual situation of the Company, I hereby report on my performance of independent director duties for the year 2025:

I. Basic Information of the Independent Director

Ms. Sun Hongxing, born in 1967, Chinese nationality, without permanent residency abroad, holds a master's degree in management from Shanghai University of Finance and Economics. Currently, she serves as an associate professor at the School of Accounting, Shanghai University of Finance and Economics; has been an independent director of the Company since September 1, 2022; an independent director of Shanghai Yayun Textile Chemical Co., Ltd. since July 21, 2023; and an independent director of Jiangsu Jindike Biotechnology Co., Ltd. since January 10, 2024. As of the date of this announcement, neither I nor my immediate family members or major social relations hold any position in the Company or its subsidiaries, nor do we directly or indirectly hold any shares of the Company. I do not hold any position in any shareholder unit that holds 5% or more of the Company's issued shares, and there are no related relationships with shareholders holding more than 5% of the Company's shares, actual controllers, other directors, or senior management. My qualifications and conditions meet the requirements for independence as stipulated in the "Measures for the Administration of Independent Directors of Listed Companies," and there are no circumstances affecting my independence.

II. Overview of Independent Director's Annual Performance

  1. Attendance at Board and Shareholder Meetings In 2025, the convening of the Company's board and shareholder meetings complied with legal procedures, and major operational decisions and other significant matters were carried out according to relevant regulations.

(1) Attendance at Board Meetings
During the reporting period, I attended all 6 board meetings in person, with no proxy attendance or absences, and did not miss two consecutive board meetings, strictly adhering to the relevant regulations for board attendance. Throughout my tenure, I have maintained a diligent and responsible principle in my duties, carefully reviewing all meeting proposals and maintaining effective communication with the Company's management to ensure that the proposals align with the Company's development reality and comply with laws, regulations, and the Articles of Association. As an independent director, I raised no objections to any board proposals and voted in favor of all proposals discussed at the board meetings.

(2) Attendance at Shareholder Meetings
During the reporting period, the Company held 2 shareholder meetings, both of which I attended in full. During the meetings, I actively participated in the review and voting of proposals, listened to shareholders' opinions and suggestions regarding the Company's operational and financial conditions, and effectively fulfilled my supervisory responsibilities as an independent director.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.